Pricing

Processa Pharmaceuticals Inc (PCSA)

followers ·
Sector:
INDUSTRIALS
Industry:
MACHINERY
SIC:
PHARMACEUTICAL PREPARATIONS
CEO:
David Young
Employees:
20
7380 COCA COLA DRIVE, SUITE 106, HANOVER, MD, 21076
443-776-3133
    Formally known as:
  • PROCESSA PHARMACEU

Are you looking for this stock instead?

Stock Split History
DateRatio
2017-12-08 1:7
2019-12-23 1:7
2024-01-22 1:20
Processa Pharmaceuticals, Inc. focuses on the development of drug products for the treatment of patients with unmet medical needs in the United States. Its lead product candidate is PCS499, an oral tablet that is in Phase 2B clinical trials for the. treatment of ulcerative and non-ulcerative necrobiosis lipoidica, a chronic disfiguring condition. The company was incorporated in 2011 and is based in Hanover, Maryland.
All 13F Filers Prior Change Hedge Funds 1 Prior Change
InvestorHistoryShares Held or Principal AmtMarket Value% of PortfolioPrevious % of PortfolioRankChange in Shares% OwnershipQtr 1st OwnedEst. Avg PriceSourceSource DateDate Reported
No data available